Effect of Verapamil Tablets on the Pharmacokinetic of HRS-1893 Tablets in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 26, 2024

Primary Completion Date

May 20, 2024

Study Completion Date

May 20, 2024

Conditions

Obstructive Hypertrophic Cardiomyopathy

Interventions

DRUG

HRS-1893 tablet

HRS-1893 tablet single dose

DRUG

Verapamil tablet

Verapamil tablet 80 mg tid

Trial Locations (1)

Beijing Anzhen Hospital, Beijing

All Listed Sponsors

lead

Shandong Suncadia Medicine Co., Ltd.

INDUSTRY

NCT06354556 - Effect of Verapamil Tablets on the Pharmacokinetic of HRS-1893 Tablets in Healthy Subjects | Biotech Hunter | Biotech Hunter